Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.
Medically reviewed by Min Clinic Staff | Updated: January 2026
Dosing and uses of Parsabiv (etelcalcetide)
Hyperparathyroidism
Pending FDA approval for treatment of secondary hyperparathyroidism (SHPT) for patients with chronic kidney disease (CKD) on hemodialysis
Pharmacology of Parsabiv (etelcalcetide)
Mechanism of action
Calcium-sensing receptor (CaSR) agonist
